Prevalence and Factors Related to Substance Use among Adolescents with Eating DisordersCastro-Fornieles J.a, c, d · Díaz R.a · Goti J.a · Calvo R.a · Gonzalez L.a · Serrano L.a · Gual A.b, c
aDepartment of Child and Adolescent Psychiatry and Psychology, Institute Clinic of Neurosciences, Hospital Clínic Universitari, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), bDepartment of Psychiatry, Alcohol Unit, Institute of Neurosciences, Hospital Clínic Universitari of Barcelona, cIDIBAPS (Institut d’Investigacions Biomèdiques August Pi Sunyer), and dDepartment of Psychiatry and Clinical Psychobiology, Health Sciences Division, University of Barcelona, Barcelona, Spain
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Objective: Very few studies have assessed substance use in clinical samples of adolescents with eating disorders (ED). This paper reports the prevalence of regular or risky substance use (RRSU) and substance use disorder (SUD) in adolescents with ED. Methods: The Teen-Addiction Severity Index (T-ASI), the Youth Self-Report (YSR) scale and substance use questionnaires were administered to 95 adolescent patients aged 12–17 years who fulfilled the DSM-IV-TR diagnostic criteria for anorexia nervosa, bulimia nervosa and ED not otherwise specified. All patients were consecutively attended at an Eating Disorders Unit. Results: 14.7% presented SUD related to tobacco, 3.2% to cannabis, 1.1% to alcohol, and 1.1% to other substances. Patients with RRSU-SUD of any substance except tobacco were 34.7%. Patients with RRSU-SUD failed more subjects, repeated more school years and had higher scores on T-ASI scales of problems at school, family function and social relationships, and on YSR scales of delinquent behavior and externalizing problems. Conclusions: Substance use problems in ED adolescents are frequent and formal screening of them as well as a specific therapeutic approach are necessary.
© 2009 S. Karger AG, Basel
- Vega WA, Aguilar-Gaxiola S, Andrade L, Bijil R, Borges G, Caraveo-Anduaga JJ, DeWitt DJ, Heeringa SG, Kessler RC, Kolody B, Merikangas KR, Molnar BE, Walters EE, Warner LA, Wittchen HU: Prevalence and age of onset for drug use in seven international sites: results from the international consortium of psychiatric epidemiology. Drug Alcohol Depend 2002;68:285–297.
Observatorio Español sobre Drogas. Encuestas sobre drogas a población escolar, 1996–1006 y Encuestas domiciliarias sobre consumo de drogas, 1995–2005. Madrid: Delegación del Gobierno para el Plan Nacional sobre Drogas (Spanish Drug Watch. Drug Use among the School Population Survey, 1996–2006 and Home Survey on Drug Use, 1995–2005. Madrid, National Drugs Plan).
Pérez-Gaspar M, Gual P, de Irala-Estévez J, Martínez-González MA, Lahortiga F, Cervera S: Prevalencia de trastornos de la conducta alimentaria en las adolescentes navarras. Med Clin (Barc) 2000;114:481–486.
- Piran N, Robinson S: The association between disordered eating and substance use and abuse in women: a community-based investigation. Women Health 2006;44:1–20.
- Piran N, Robinson S: Associations between disordered eating behaviours and licit and illicit substance use and abuse in a university sample. Addict Behav 2006;31:1761–1775.
- Chamay-Weber C, Narring F: Medications and drug consumption among adolescent girls and boys with weight and eating concern. J Adolesc Health 2006;38:160.
- Stock SL, Goldberg E, Corbett S, Katzman DK: Substance use in female adolescents with eating disorders. J Adolesc Health 2002;31:176–182.
- Von Ranson KM, Iacono WG, McGue M: Disordered eating and substance use in an epidemiological sample. I. Associations within individuals. Int J Eat Disord 2002;31:389–403.
- Courbasson CMA, Smith PD, Cleland PA: Substance use disorders, anorexia, bulimia and concurrent disorders. Can J Public Health 2005;96:102–106.
- Bulik CM, Klump KL, Thornton L, Kaplan AS, Devlin B, Fichter MM, Halmi KA, Strober M, Woodside DB, Crow S, Mitchell JE, Rotondo A, Mauri M, Cassano GB, Keel PR, Berrettini WH, Kaye WH: Alcohol use disorder comorbidity in eating disorders: a multicenter study. J Clin Psychiatry 2004;65:1000–1006.
- Duncan AE, Neuman RJ, Kramer JR, Kuperman S, Hesselbrock VM, Bucholz KK: Lifetime psychiatric comorbidity of alcohol dependence and bulimia nervosa in women. Drug Alcohol Depend 2006;84:122–132.
- Franko DL, Dorer DJ, Keel PK, Jackson S, Manzo MP, Herzog DB: How do eating disorders and alcohol use disorder influence each other? Int J Eat Disord 2005;38:200–207.
- Keel PK, Dorer DJ, Kamryn TE, Franko D, Charatan DL, Herzog DB: Predictors of mortality in eating disorders. Arch Gen Psychiatry 2003;60:179–183.
- Redgrave GW, Coughlin JW, Heinberg LJ, Guarda AS: First-degree relative history of alcoholism in eating disorder inpatients: relationship to eating and substance use psychopathology. Eat Behav 2007;8:15–22.
- Herzog DB, Franko DL, Dorer DJ, Keel PK, Jackson S, Manzo MP: Drug abuse in women with eating disorders. Int J Eat Disord 2006;39:364–368.
- Wiederman MW, Pryor T: Substance abuse among women with eating disorders. Int J Eat Disord 1996;20:163–168.
- Lilenfeld LR, Kaye WH, Greeno CG, Merikangas KR, Plotnicov K, Pollice C, Rao R, Strober M, Bulik CM, Nagy L: Psychiatric disorders in women with bulimia nervosa and their first-degree relatives: effects of comorbid substance dependence. Int J Eat Disord 1997;22:253–264.
- Nagata T, Kawarada Y, Ohshima J, Iketani T, Kiriike N: Drug use disorders in Japanese eating disorder patients. Psychiatry Res 2002;109:181–191.
- Wiederman MW, Pryor T: Substance use and impulsive behaviours among adolescents with eating disorders. Addict Behav 1996;21:269–272.
- Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JI, Reig T, Schmidt T, Schuckit MA: A new, semi-structured psychiatric interview for use in genetic linkage studies: a report of the reliability of the SSAGA. J Stud Alcohol 1994;55:149–158.
- Hesselbrock M, Easton C, Bucholz KK, Schuckit M, Hesselbrock V: A validity study of the SSAGA-A. A comparison with the SCAN. Addiction 1999;94:1361–1370.
Hollinshead AB: Four Factor Index of Social Status. New Haven, Yale University Department of Sociology, 1990.
Kaminer Y, Wagner E, Plummer B: Validation of the Teen Addiction Severity Index (T-ASI). Am J Addict 1993;2:250–254.
- Diaz R, Castro-Fornieles J, Serrano L, Gonzalez L, Calvo R, Goti J, Kaminer Y, Gual A: Clinical and research utility of Spanish Teen-Addiction Severity Index (T-ASI). Addict Behav 2008;33:188–195.
- McLellan AT, Luborsky L, Cacciola J, Griffith JE, Evans F, Barr HL, O’Brien CP: New data from the Addiction Severity Index: reliability and validity in three centers. J Nerv Ment Dis 1985;173:412–423.
- Jessor R, Van der Bos J, Vanderryn J, Costa F, Turbin M: Protective factors in adolescent problem behaviour: moderator effects and developmental change. Dev Psychol 1995;31:923–933.
Achenbach TM: Manual for the Youth Self-Report and 1991 Profile. Burlington, University of Vermont, Department of Psychiatry, 1991.
- Shrier LA, Harris SK, Kurland M, Knight JR: Substance use problems and associated psychiatric symptoms among adolescents in primary care. Pediatrics 2003;111:e699–e705.
- Hingson RW, Heeren T, Winter MR: Age of alcohol-dependence onset: associations with severity of dependence and seeking treatment. Pediatrics 2006;118:e755–e763.
- King KM, Chassin L: A prospective study of the effects of age of initiation of alcohol and drug use on young adult substance dependence. J Stud Alcohol Drugs 2007;68:256–265.
- Winters KC, Lee CY: Likelihood of developing an alcohol and cannabis use disorder during youth: association with recent use and age. Drug Alcohol Depend 2008;92:239–247.
- Chen H, Cohen P, Johnson JG, Kasen S: Psychiatric disorders during adolescence and relationships with peers from age 17 to age 27. Soc Psychiatry Psychiatr Epidemiol 2009;44:223–230.
- Conrod PJ, Castellanos N, Mackie C: Personality-targeted interventions delay the growth of adolescent drinking and binge drinking. J Child Psychol Psychiatry 2008;49:181–190.
- Benjet C, Borges G, Medina-Mora ME, Fleiz C. Blanco J, Zambrano J, Roja E, Ramirez M: Prevalence and socio-demographic correlates of drug use among adolescents: results from the Mexican adolescent mental health survey. Addiction 2007;102:1261–1268.
- Perkonigg A, Pfister H, Hofler M, Frohlich C, Zimmermann P, Lieb R, Wittchen HY: Substance use and substance use disorders in a community sample of adolescents and young adults: incidence, age effects and patterns of use. Eur Addict Res 2006;12:187–196.
- Weaver MF, Dupre MA, Cropsey KL, Koch JR, Sood BA, Wiley JL: Addiction epidemiology in adolescents receiving inpatient psychiatric treatment. Addict Behav 2007;32:3107–3113.
- Gilpin EA, White MM, Messer K, Pierce JP: Receptivity of tobacco advertising and promotions among young adolescents as a predictor of established smoking in young adulthood. Am J Public Heath 2007;97:1489–1495.
- D’Amico EJ, McCarthy M: Escalation and initiation of younger adolescents’ substance use: the impact of perceived peer use. J Adolesc Health 2006;39:481–489.
- Georgiades K, Boyle MH: Adolescent tobacco and cannabis use: young adult outcomes from the Ontario Child Health Study. J Child Psychol Psychiatry 2007;48:724–731.
- Thompson-Brenner H, Eddy KT, Franko DL, Dorer D, Vashchenko M, Herzog DB: Personality pathology and substance abuse in eating disorders: a longitudinal study. Int J Eat Disord 2008;41:203–208.
- Melchior M, Moffitt TE, Milne BJ, Poulton R, Caspi A: Why do children from socioeconomically disadvantaged families suffer form poor health when they reach adulthood? A life-course study. Am J Epidemiol 2007;166:966–974.
- Gau SS, Chong MY, Yang P, Yen CF, Liang KY, Cheng AT: Psychiatric and psychosocial predictors of substance use disorders among adolescents: longitudinal study. Br J Psychiatry 2007;190:42–48.
- Henry KL, Huizinga DH: Truancy’s effect on the onset of drug use among urban adolescents placed at risk. J Adolesc Health 2007;40:358.e9–e17.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.